Cooperman Barnabas Medical Center — Livingston, New Jersey

Cooperman Barnabas Medical Center is a clinical research site located in Livingston, New Jersey, United States 07039.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

Cooperman Barnabas Medical Center has participated in 59 clinical trials with 52 currently active.

Therapeutic areas: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.

Sponsors: National Cancer Institute (NCI), Rutgers, The State University of New Jersey, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Livingston

Browse all research sites in New Jersey · View every site in Livingston

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cooperman Barnabas Medical Center?

Cooperman Barnabas Medical Center has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cooperman Barnabas Medical Center conducted?

Cooperman Barnabas Medical Center has 59 clinical trials on record, with 52 currently active. Their work covers Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.

Is Cooperman Barnabas Medical Center accredited by Crixeo Clinical Trials?

Cooperman Barnabas Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cooperman Barnabas Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.